差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 Calcimedica Inc - CALC CFD

5.2188
5.9%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.5324
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 0.001
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 5.5461
開盤價* 5.4479
1 年變化* 342.92%
日範圍* 4.9053 - 5.6656
52 周範圍 4.88-20.30
平均交易量（10 天） 25.61K
平均交易量（3 個月） 115.32K
市值 31.45M
市盈率 -100.00K
流通股 5.52M
收入 N/A
EPS -23.21
股息（收益率 %） N/A
貝塔 -100.00K
下一個財報發布日期 May 8, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 28, 2023 5.2188 -0.1502 -2.80% 5.3690 5.8530 4.9029
Mar 27, 2023 5.5461 0.1553 2.88% 5.3908 6.0853 5.3883
Mar 24, 2023 5.5507 0.0832 1.52% 5.4675 5.7853 5.4675
Mar 23, 2023 5.4929 0.1525 2.86% 5.3404 5.8023 5.3404
Mar 22, 2023 5.5768 0.2301 4.30% 5.3467 6.5507 5.0805
Mar 21, 2023 6.0468 1.2311 25.56% 4.8157 6.1436 4.7284
Mar 20, 2023 5.3451 -0.6469 -10.80% 5.9920 5.9920 5.0602
Mar 17, 2023 0.4280 -0.0478 -10.05% 0.4758 0.4763 0.4273
Mar 16, 2023 0.4761 -0.0195 -3.93% 0.4956 0.4958 0.4580
Mar 15, 2023 0.4937 0.0277 5.94% 0.4660 0.4969 0.4660
Mar 14, 2023 0.4762 -0.0145 -2.95% 0.4907 0.4957 0.4737
Mar 13, 2023 0.4960 -0.0093 -1.84% 0.5053 0.5151 0.4859
Mar 10, 2023 0.5041 0.0008 0.16% 0.5033 0.5120 0.4857
Mar 9, 2023 0.5346 -0.0034 -0.63% 0.5380 0.5637 0.5164
Mar 8, 2023 0.5638 0.0408 7.80% 0.5230 0.5647 0.5230
Mar 7, 2023 0.5637 0.0395 7.54% 0.5242 0.5823 0.5242
Mar 6, 2023 0.5556 -0.0273 -4.68% 0.5829 0.5829 0.5537
Mar 3, 2023 0.5476 0.0429 8.50% 0.5047 0.5588 0.5047
Mar 2, 2023 0.5345 0.0292 5.78% 0.5053 0.5347 0.5053
Mar 1, 2023 0.5390 0.0045 0.84% 0.5345 0.5832 0.5339

Calcimedica Inc Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2022 2021 2020 2019 2018
總收入 0 0 0 0 0
總營業費用 36.18 35.947 29.832 37.502 28.57
銷售/一般/行政費用，總計 19.104 17.044 8.87 6.922 5.599
研究與開發 14.113 18.903 20.962 30.58 22.971
營業收入 -36.18 -35.947 -29.832 -37.502 -28.57
利息收入（費用），非經營淨值 0.575 0.126 0.143 0.393 0.192
其他，淨值 0 2.158 0.072 0
稅前淨收入 -35.605 -35.821 -27.531 -37.037 -28.378
稅後淨收入 -35.605 -35.821 -27.531 -37.037 -28.378
未計算非常項目前的淨收益 -35.605 -35.821 -27.531 -37.037 -28.378
淨收入 -35.605 -35.821 -27.531 -37.037 -28.378
Total Adjustments to Net Income 0 -7.189 -7.055 -4.317
普通股股東可獲收益 (不含非經常性項目) -35.605 -35.821 -34.72 -44.092 -32.695
普通股股東可獲收益 (含非經常性項目) -35.605 -35.821 -34.72 -44.092 -32.695
攤薄淨收入 -35.605 -35.821 -34.72 -44.092 -32.695
攤薄後加權平均股 1.53498 1.51427 1.50317 1.36829 1.36829
扣除特別項目的每股攤薄盈利 -23.1957 -23.6557 -23.0978 -32.2243 -23.8949
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -21.2654 -23.6557 -23.0978 -32.2243 -23.8949
異常費用（收入） 2.963
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
總收入 0 0 0 0 0
總營業費用 7.712 9.983 8.301 10.184 8.701
銷售/一般/行政費用，總計 6.435 4.299 4.243 4.127 4.433
研究與開發 0.749 3.249 4.058 6.057 4.268
營業收入 -7.712 -9.983 -8.301 -10.184 -8.701
利息收入（費用），非經營淨值 0.309 0.171 0.06 0.035 0.026
其他，淨值 0
稅前淨收入 -7.403 -9.812 -8.241 -10.149 -8.675
稅後淨收入 -7.403 -9.812 -8.241 -10.149 -8.675
未計算非常項目前的淨收益 -7.403 -9.812 -8.241 -10.149 -8.675
淨收入 -7.403 -9.812 -8.241 -10.149 -8.675
Total Adjustments to Net Income 0
普通股股東可獲收益 (不含非經常性項目) -7.403 -9.812 -8.241 -10.149 -8.675
普通股股東可獲收益 (含非經常性項目) -7.403 -9.812 -8.241 -10.149 -8.675
攤薄淨收入 -7.403 -9.812 -8.241 -10.149 -8.675
攤薄後加權平均股 1.54484 1.53836 1.53099 1.52559 1.52415
扣除特別項目的每股攤薄盈利 -4.79207 -6.37822 -5.3828 -6.65253 -5.69171
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 -4.45029 -4.79536 -5.3828 -6.65253 -5.69171
異常費用（收入） 0.528 2.435
  • 年度
  • 每季度
2021 2020 2019 2018
流動資産總額 67.078 99.24 36.271 13.445
現金和短期投資 63.67 95.033 35.956 12.834
現金等價物 13.364 33.418 15.87 12.834
短期投資 50.306 61.615 20.086 0
Prepaid Expenses 2.034 4.207 0.315 0.611
Total Assets 69.088 101.794 40.66 17.813
Property/Plant/Equipment, Total - Net 1.981 1.946 1.975 1.515
Property/Plant/Equipment, Total - Gross 3.634 3.08 2.714 1.958
Accumulated Depreciation, Total -1.653 -1.134 -0.739 -0.443
Other Long Term Assets, Total 0.029 0.608 2.414 2.853
Total Current Liabilities 4.057 6.997 12.251 5.794
Accounts Payable 0.527 2.513 4.636 2.523
Accrued Expenses 2.582 3.658 4.377 2.924
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.948 0.826 3.238 0.347
Total Liabilities 4.065 7.008 12.251 5.794
Total Long Term Debt 0 0 0 0
Total Equity 65.023 94.786 28.409 12.019
Preferred Stock - Non Redeemable, Net 0 0 131.363 78.811
Common Stock 0.002 0.002 0 0
Additional Paid-In Capital 234.225 228.155 2.879 2.007
Retained Earnings (Accumulated Deficit) -169.188 -133.367 -105.836 -68.799
Unrealized Gain (Loss) -0.016 -0.004 0.003 0
Total Liabilities & Shareholders’ Equity 69.088 101.794 40.66 17.813
Total Common Shares Outstanding 21.3578 20.9793 19.1556 19.1556
Other Liabilities, Total 0.008 0.011
Total Preferred Shares Outstanding 0
應收賬款總額，淨額 0.021
Other Current Assets, Total 1.353
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 58.222 67.078 74.496 76.051 88.821
現金和短期投資 55.28 63.67 72.554 73.586 85.688
現金等價物 8.36 13.364 11.452 7.864 10.589
短期投資 46.92 50.306 61.102 65.722 75.099
Prepaid Expenses 2.942 3.408 1.942 2.465 3.133
Total Assets 60.586 69.088 76.638 82.821 90.852
Property/Plant/Equipment, Total - Net 2.335 1.981 2.113 2.006 2.002
Other Long Term Assets, Total 0.029 0.029 0.029 0.136 0.029
Total Current Liabilities 4.228 4.057 4.49 4.141 6.278
Accounts Payable 0.541 0.527 2.066 2.101 1.956
Accrued Expenses 2.216 2.582 1.729 1.543 3.378
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.471 0.948 0.695 0.497 0.944
Total Liabilities 4.33 4.065 4.502 4.154 6.29
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.102 0.008 0.012 0.013 0.012
Total Equity 56.256 65.023 72.136 78.667 84.562
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 235.767 234.225 232.641 231.183 229.376
Retained Earnings (Accumulated Deficit) -179.337 -169.188 -160.513 -152.524 -144.816
Unrealized Gain (Loss) -0.176 -0.016 0.006 0.006 0
Total Liabilities & Shareholders’ Equity 60.586 69.088 76.638 82.821 90.852
Total Common Shares Outstanding 21.3578 21.3578 21.3166 21.2847 21.0559
Long Term Investments 4.628
Preferred Stock - Non Redeemable, Net 0 0
  • 年度
  • 每季度
2021 2020 2019 2018
淨收入/起跑線 -35.821 -27.531 -37.037 -28.378
經營活動産生的現金 -31.5 -32.064 -31.215 -28.216
經營活動産生的現金 0.519 0.395 0.303 0.175
非現金物品 5.433 -0.369 0.598 0.366
營運資金的變化 -1.631 -4.559 4.921 -0.379
投資活動産生的現金 10.751 -42.56 -20.62 -1.461
資本支出 -0.488 -1.023 -0.605 -1.461
其他投資現金流量項目，總計 11.239 -41.537 -20.015 0
融資活動産生的現金 0.695 92.172 54.871 42.019
融資現金流項目 0 -4.16 -0.045 0
股票的發行（報廢），淨額 0.695 96.332 54.916 42.019
現金淨變化 -20.054 17.548 3.036 12.342
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -10.149 -35.821 -27.146 -19.157 -11.449
Cash From Operating Activities -6.524 -31.5 -22.545 -17.045 -9.264
Cash From Operating Activities 0.122 0.519 0.383 0.247 0.118
Non-Cash Items 3.81 5.433 3.946 2.508 1.169
Changes in Working Capital -0.307 -1.631 0.272 -0.643 0.898
Cash From Investing Activities 1.52 10.751 -0.035 -9.096 -13.657
Capital Expenditures 0 -0.488 -0.484 -0.304 -0.136
Other Investing Cash Flow Items, Total 1.52 11.239 0.449 -8.792 -13.521
Cash From Financing Activities 0 0.695 0.614 0.587 0.092
Financing Cash Flow Items 0 0 0 0
Issuance (Retirement) of Stock, Net 0 0.695 0.614 0.587 0.092
Net Change in Cash -5.004 -20.054 -21.966 -25.554 -22.829
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Deerfield Management Company, L.P. Hedge Fund 6.8373 377265 0 2022-12-31 MED
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 5.3895 297380 -2 2023-03-24 LOW
Wilson (Robert N) Individual Investor 11.5614 181655 181655 2023-03-20
BML Capital Management LLC Investment Advisor 1.6 88282 0 2022-12-31 MED
Breuil (Robert S) Individual Investor 0.6207 34246 29340 2023-03-23 HIGH
Zamiri (Parisa) Individual Investor 0.6002 33117 30424 2023-03-23 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.5436 29995 13 2022-12-31 LOW
CVF 2018, LLC Corporation 0.3531 19485 -56817 2021-12-31
First Manhattan Co. LLC Investment Advisor 0.3512 19381 -1476 2022-12-31 LOW
Stauderman (Kenneth A. Ph.D.) Individual Investor 0.7602 11944 11944 2023-03-20
Renaissance Technologies LLC Hedge Fund 0.2019 11143 -3178 2022-12-31 HIGH
Guerard (Frederic) Individual Investor 0.0388 8409 1218 2022-12-01 LOW
BNY Mellon Asset Management Investment Advisor 0.1297 7159 -54 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.0857 4730 -12 2022-12-31 LOW
Johnson & Johnson Innovation-JJDC, Inc. Venture Capital 0.0641 3539 0 2022-12-31 LOW
Susquehanna International Group, LLP Investment Advisor 0.0581 3204 -1313 2022-12-31 MED
Hatteras Venture Partners Venture Capital 0.0557 3076 -111584 2021-12-31 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.0542 2993 -1578 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0454 2505 0 2022-12-31 LOW
Bjerkholt (Eric H) Individual Investor 0.0259 1429 1429 2023-03-23 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

505 Coast Boulevard South
Suite 307
LA JOLLA
CALIFORNIA 92037
US

收入報表

  • Annual
  • Quarterly

人們也觀看

Gold

1,961.99 Price
-0.640% 1D Chg, %
多頭倉位隔夜費用 -0.0180%
空頭倉位隔夜費用 0.0097%
隔夜費時間 21:00 (UTC)
價差 0.30

XRP/USD

0.55 Price
+3.560% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00514

Oil - Crude

73.72 Price
+0.150% 1D Chg, %
多頭倉位隔夜費用 -0.0153%
空頭倉位隔夜費用 -0.0066%
隔夜費時間 21:00 (UTC)
價差 0.03

US100

12,699.50 Price
+0.670% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 1.8

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易